Tuesday, 20 July 2021

Surgical Microscopes Market to Reach USD 2.3 Billion by 2028: Grand View Research Inc.

 Surgical Microscopes Market Growth & Trends

The global surgical microscopes market size is expected to reach USD 2.3 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.1% from 2021 to 2028. The rising need for ophthalmic procedures, rapid adoption of surgical microscopes in cosmetic surgeries, and new product launches are factors driving the growth of the market. For instance, in October 2018, Med X Change, Inc. launched 4Klear, a 4K Camera & Medical Video Recorder for surgical microscopes. Ophthalmic, neurological, cosmetic, and other minimally invasive surgeries require utmost precision and accuracy.

This can only be achieved through superior visualization tools. Surgical microscopes offer improved visibility, stability, recording capabilities, illumination, and high magnification of minute veins. This has led to increased demand for the product among physicians. These tools have revolutionized the field of minimally invasive surgeries as they allow surgeons to perform surgeries with maximum precision on actual pathology by magnifying the surrounding anatomical structures, resulting in improved patient outcomes with a shorter duration of procedures and rapid recovery.

In addition, limitations of open surgeries have been significantly eliminated by integrating the workflow in operating rooms. Thus, the majority of surgeons are adopting minimally invasive surgeries in various medical fields worldwide. Furthermore, people in emerging economies are willing to pay for premium-quality services due to increasing disposable income, which is anticipated to drive market growth during the forecast period. North America dominated the market in 2020 and will grow at a steady CAGR from 2021 to 2028. The growth is credited to the rising adoption of microsurgeries, favorable health reimbursement programs, and the presence of major manufacturers in the region.

Asia Pacific is expected to witness the fastest CAGR from 2021 to 2028 owing to rising cases of ophthalmic and neurological disorders that require microsurgical treatment and the growing demand for advanced surgical microscopes in hospitals for complex procedures. In response to the COVID-19 pandemic, hospitals decided to suspend all the elective and non-urgent surgeries, which have negatively impacted the market. However, with the ease of restrictions, treatments are resuming in many countries, including developing nations. Also, many companies, such as Alcon and Carl Zeiss, have resumed their business operations with the given government guidelines to deliver their orders.

Request a free sample copy or view report summary: Surgical Microscopes Market Report

Surgical Microscopes Market Report Highlights

  • On casters was the largest type segment in 2020 due to the high portability & flexibility and low maintenance requirements of these tools
  • The ophthalmology application segment accounted for the maximum revenue share in 2020
  • The rising prevalence of ophthalmic diseases and an increasing number of procedures performed annually in every region to treat various eye disorders are primary factors responsible for the segment’s high share
  • Major market participants focus on R&D and new product development to gain a competitive edge over others
  • For instance, in December 2019, Topcon Medical Systems launched SL-D4 LED illumination Slit Lamp for application in ophthalmic procedures

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-microscope-market

Surgical Microscopes Market Segmentation

Grand View Research has segmented the global surgical microscopes market on the basis of type, application, end-use, and region:

Surgical Microscope Type Outlook (Revenue, USD Million, 2016 - 2028)

  • On Casters
  • Wall Mounted
  • Tabletop
  • Ceiling Mounted

Surgical Microscope Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Ophthalmology
  • Neurosurgery
  • Spine Surgery
  • ENT Surgery
  • Dentistry
  • Plastic & Reconstructive Surgeries
  • Gynecology
  • Urology
  • Other Surgeries

Surgical Microscope End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospital
  • Physician Clinics & Others Settings

Surgical Microscope Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • Italy
    • UK.
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa (MEA)
    • South Africa
    • Egypt

List of Key Players of Surgical Microscopes Market

  • Carl Zeiss Meditec AG
  • Leica Microsystems
  • Olympus Corp.
  • Hagg-Streit Surgical GmbH
  • Synaptive Medical
  • Alcon, Inc.
  • Topcon Corp.
  • Takagi Seiko Co., Ltd.
  • ARI Medical Technology Co., Ltd.
  • Chammed Co., Ltd.
  • Seiler Instrument, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Payment Gateway Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 Payment Gateway Market Growth & Trends

The global payment gateway market size is expected to reach USD 87.44 billion by 2028, registering a CAGR of 21.7% from 2021 to 2028, according to a new report by Grand View Research, Inc. The market growth can be attributed to the increasing use of payment gateway methods for online shopping across the globe. The shift in consumers’ and merchants’ preference toward digital channels for money transfer has also been instrumental in propelling the market growth.

Most companies are opting for payment gateways as they allow secure internet transactions. This helps them prevent debit or credit card scams and other fraudulent activities. Additionally, gateway services provide consumers with access to online sellers across the world, thereby allowing merchants to efficiently increase their customer base.

Payment gateways enable merchants to automate the complete money transfer process with faster processing speed and error-free computations. Moreover, they eliminate the need for consumers to deal with the hassles of shopping from physical stores and waiting in long queues. Consumers can effectively complete their entire transaction online, thus offering them a seamless shopping experience.

The growing trend of digitalization and the high adoption rate of numerous online money transfer modes, including net banking and mobile wallets, are anticipated to propel market growth over the forecast period. The advent of applications that are compatible with different smartphones to enable online money transfer is also contributing to the market growth. Additionally, factors such as the merging of numerous e-commerce sites with gateway platforms, partnerships of banks with online retailers, and attractive cashback offer on online payments are expected to offer growth prospects for the market over the forecast period.

The global COVID-19 pandemic has resulted in the rising use of contactless payment methods for making transactions in drug and grocery stores. According to a study conducted by Mastercard in 2020, 79% of people worldwide use contactless payment methods, citing hygiene and safety measures as the key drivers. Moreover, the pandemic has accelerated the growth of digital technology and e-commerce. Fintech company stocks have garnered significant attention as the digital payment platforms impact payment networks, e-commerce, business-to-business payments, and others. Payment gateway companies are, thereby, witnessing an increase in funding. For instance, in March 2021, Stripe-a payment gateway company-was valued at USD 95 billion after its USD 600 million funding round. In the wake of the pandemic, around 200,000 companies signed up on Stripe, making the value of the company reach an estimated USD 115 billion by 2021.

Request a free sample copy or view report summary: Payment Gateway Market Report

Payment Gateway Market Report Highlights

  • The hosted segment is expected to continue its dominance over the forecast period owing to the features such as easy payment integration, built-in compliance capabilities, and the ability to integrate more diverse methods
  • The small and medium enterprise segment is expected to witness significant growth over the forecast period. Payment gateways are used by small and medium enterprises to significantly uplift their profitability by delivering a better customer experience and reducing transaction costs.
  • The retail and e-commerce sector dominated the market in 2020. Factors such as better shopping experience and increased smartphone penetration are expected to increase the adoption of payment gateway systems in the retail and e-commerce segment
  • North America dominated the market in 2020 and is expected to showcase similar trends in the forthcoming years. The growing e-commerce sales and rapidly changing retail market in North America are the primary factors propelling the demand for fast payment solutions in the region. This, as a result, is fueling the regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-payment-gateway-market

Payment Gateway Market Segmentation

Grand View Research has segmented the global payment gateway market based on type, enterprise size, end use, and region:

Payment Gateway Type Outlook (Revenue, USD Billion, 2016 - 2028)

  • Hosted
  • Non-hosted

Payment Gateway Enterprise Size Outlook (Revenue, USD Billion, 2016 - 2028)

  • Large Enterprises
  • Small & Medium Enterprises

Payment Gateway End-use Outlook (Revenue, USD Billion, 2016 - 2028)

  • BFSI
  • Media & Entertainment
  • Retail & E-commerce
  • Travel & Hospitality
  • Others

Payment Gateway Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa

List of Key Players of Payment Gateway Market

  • Adyen
  • Amazon Payments Inc.
  • Net
  • Bitpay, Inc.
  • Braintree
  • PayPal Holdings Inc.
  • PayU Group
  • Stripe
  • Verifone Holdings Inc.
  • Wepay, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Egypt Ride Hailing Service Market Strong Application and Emerging Trends also Scope by 2028: Grand View Research Inc.

 Egypt Ride Hailing Service Market Growth & Trends

The Egypt ride hailing service market size is anticipated to reach USD 2.99 billion by 2028, according to a new report by Grand View Research, Inc. The market is projected to register a CAGR of 15.8% from 2021 to 2028. The emergence of ride hailing services has opened a new avenue in the field of public transportation. The service providers, often known as transportation network companies, are claimed to be the new future of public transport. The service enables customers to hire personal drivers who drive them from one place to another, as required.

These rides are extremely convenient as they provide numerous alternatives with customization options. Customers can choose the pick-up/drop-off location, preferred route, number of riders, number of stops, as well as the type of vehicle. Many transportation network companies also offer ride-sharing services. Another reason for their rapid adoption is that the service provides an instant solution to traffic congestion and parking difficulties.

The service has evolved as a massive alternative to personal vehicles, traditional taxi services, and community transports. Following the trend across the globe, the Egypt ride hailing service market can also be seen heating up. Lucrative growth prospects have been enticing both domestic as well as international transportation network companies to the market.

According to the World Bank, Egypt’s population is estimated at 98.42 million as of 2018. Regular means of transportation, such as personal vehicles, traditional taxi services, and community transport services like mini-buses, tuk-tuks, and motorbikes no more suffice the requirements of the country. Along with this, the traffic situation has worsened over the years with an increase in the number of personal vehicles.

As a result, ride hailing services have been experiencing massive growth. The market is being largely dominated by UBER, Dubci, and WNGO. This spur, along with technological advancements, is expected to maintain the dynamic nature of the market. The car-hailing market has gradually established itself in Egypt.

Companies in the market are focusing on strategies such as mergers and acquisitions to gain market share and to increase their service footprint. For Instance, In November 2018, Avis Budget Group Inc. partnered with Ford's Transportation Mobility Cloud to enable data to flow from vehicles through Ford's data systems and onto Avis' computers. Through this, the company aims to puts more control in the customer's hands, while at the same time reducing costs and vehicle turnaround times. By adding connected functionality to their vehicles and their mobile app, Avis measured a corresponding 30% increase in their Net Promoter Score. The data from Avis's connected Ford vehicles are tracked primarily at car pick-up and drop-off, not during the customer's rental period.

Request a free sample copy or view report summary: Egypt Ride Hailing Service Market Report

Egypt Ride Hailing Service Market Report Highlights

  • E-hailing is projected to be the fastest-growing segment by progressing at a CAGR of 18.9% over the forecast period
  • The car-sharing segment is foreseen to remain at the forefront regarding revenue share and is projected to accounts for a total market share of over 40% in 2028
  • Some of the key players operating in the market include Uber Technologies, Inc.; Avis Rent a Car System, LLC; Sixt SE; Halan Inc.; and SWVL Technologies Inc.

Access Press Release@ https://www.grandviewresearch.com/press-release/egypt-ride-hailing-service-market-analysis

Egypt Ride Hailing Service Market Segmentation

Grand View Research has segmented the Egypt ride hailing services market based on offering:

Egypt Ride Hailing Service Offering Outlook (Revenue, USD Million, 2016 - 2028)

  • Car Sharing
  • E-hailing
  • Rental

List of Key Players of Egypt Ride Hailing Service Market

  • Uber Technologies, Inc.
  • Avis Rent a Car System, LLC
  • Sixt SE
  • Halan Inc.
  • Wngo Technologies Inc.
  • SWVL Technologies Inc.
  • Dubci
  • Fyonka
  • FriendyCar
  • M Car Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tunisia Pharmaceutical Market Poised to Garner Maximum Revenues During 2021 – 2028: Grand View Research Inc.

 Tunisia Pharmaceutical Market Growth & Trends

The Tunisia pharmaceutical market size is estimated to reach USD 3.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.9% from 2021 to 2028. The market is largely driven by the improving pharmaceutical exports of Tunisia, which is a result of expanding pool of local pharmaceutical manufacturers in the country. The country continues to explore and capitalize on export markets, prominently Francophone countries in Africa.

Manufacturers are also engaged in on-site production in sub-Saharan nations. For instance, Tunisia-based Teriak acquired Cameroon’s Cinpharm plant in late 2015 to export in Central African markets. Despite the fact that Tunisian pharma companies have marked their presence in African markets, drug manufacturers are surrounded by several challenges including lack of infrastructure enabling direct air route, maritime connections, or business measures that hinder their growth in African countries.

Some domestic companies have begun production of medications in West Africa to reduce the import cost for countries in the region, which in turn, is providing a significant boost to the pharmaceutical industry in Tunisia. For instance, Medis was recognized as the company which exports to the largest number of countries. The company has collaborated with 11 countries. On the other hand, Teriak ranked second in the private Tunisia market in 2018 export development from 2% in 2012 to 13% in 2018.

The COVID-19 pandemic is expected to create lucrative opportunities for healthcare professionals looking to address prolonged challenges that persist in the pharmaceutical industry. Apart from the pandemic, there is a high prevalence of several chronic diseases, including cardiac, diabetes, obesity, and respiratory ailments, which can affect all age groups. This is expected to open up new avenues for healthcare professionals to develop innovative management strategies that can help in curbing pre-existing pricing challenges in the pharmaceutical industry and tackling them with the pandemic in an effective manner. 

Request a free sample copy or view report summary: Tunisia Pharmaceutical Market Report

Tunisia Pharmaceutical Market Report Highlights

  • An increase in the cases of diabetes, cardiovascular disorders, obesity, and respiratory diseases is expected to expand the pool of local drug manufacturers, thereby propelling the market growth
  • The tablets formulation segment accounted for the largest revenue share in 2020, attributed to the ease of manufacturing associated with these drug formulations
  • The capsules formulation segment is anticipated to gain significant traction in the coming years in Tunisia, registering the highest CAGR through 2021 - 2028
  • The growing popularity of soft gelatin capsules in the pharmaceutical industry is contributing to segment growth
  • The Blow-Fill-Seal (BFS) technology in injectables is being increasingly used for pharmaceutical formulation and supplementing industry momentum
  • The companies are improving local manufacturing capacities in order to sustain the market competition

Access Press Release@ https://www.grandviewresearch.com/press-release/tunisia-pharmaceutical-market-analysis

Tunisia Pharmaceutical Market Segmentation

Grand View Research has segmented the Tunisia pharmaceutical market on the basis of formulation:

Tunisia Pharmaceutical Formulation Outlook (Revenue, USD Million, 2017 - 2028)

  • Tablets
  • Capsules
  • Injectables
    • BFS-mode
    • Non-BFS-mode
  • Sprays
    • BFS-mode
    • Non-BFS-mode
  • Suspensions
    • BFS-mode
    • Non-BFS-mode
  • Powders
  • Other Formulations
    • BFS-mode
    • Non-BFS-mode

List of Key Players of Tunisia Pharmaceutical Market

  • Adwya
  • Sanofi (Sanofi-Aventis Tunisia)
  • Teriak
  • Opalia pharma
  • Les Laboratoires UNIMED
  • Medis
  • Taha Pharma
  • Cytopharma

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monday, 19 July 2021

Sternal Closure Systems Market to Grow at Moderate CAGR of 5.6% Through 2028: Grand View Research Inc.

 

Sternal Closure Systems Market Growth & Trends

The global sternal closure systems market size is expected to reach USD 3.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2021 to 2028. The market is driven by the growing number of surgeries undertaken to treat complex cardiovascular problems. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), around 30.3 million or 12.1% of U.S. adults were diagnosed with heart disease in 2018.

The National Health Interview Survey conducted by CDC in 2016 concluded that 28.1 million people were diagnosed with heart-related disorders including, valvular heart disease, cardiac arrest. Moreover, technological advancements such as Talon systems, double sternal wires, and favorable reimbursement criteria would propel growth in the near future.

Mergers and acquisitions, new product development, and geographical expansion are key sustainability strategies adopted by players in the market. For instance, in December 2020, Zimmer Biomet Holdings Inc., acquired A&E Medical Corporation to gain access to its product portfolio, ensuring long-term growth.

Request a free sample copy or view report summary: Sternal Closure Systems Market Report

Sternal Closure Systems Market Report Highlights

  • North America dominated the market in 2020, attributed to the presence of a large number of players and high competitive rivalry in the market
  • By product, the closure devices segment held major shares of the market in 2020, owing to the introduction of technologically advanced clips and wires globally and favorable reimbursement regulations offer by developed regions such as North America and Europe
  • By procedure, the median sternotomy segment dominated the market in 2020, as it is among the frequently performed osteotomies worldwide
  • By material, the PEEK segment is anticipated to post significant growth over the coming years due to several benefits offered by the material, including biocompatibility, chemical resistance, end-product purity, high-temperature resistance, and thermoformable nature

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sternal-closure-systems-market

Sternal Closure Systems Market Segmentation

Grand View Research has segmented the global sternal closure systems market based on product, procedure, material, and region:

Sternal Closure Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Closure Devices
    • Wires
    • Plates and Screws
    • Clips
    • Cables
  • Bone Cement

Sternal Closure Systems Material Outlook (Revenue, USD Million, 2016 - 2028)

  • Titanium
  • Polyether Ether Ketone (PEEK)
  • Stainless Steel
  • Others

Sternal Closure Systems Procedure Outlook (Revenue, USD Million, 2016 - 2028)

  • Median Sternotomy
  • Hemisternotomy
  • Bilateral Thoracosternotomy
  • Others

Sternal Closure Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

List of Key Players of Sternal Closure Systems Market

  • Zimmer Biomet
  • Johnson & Johnson
  • Braun Melsungen AG
  • Orthofix Holdings, Inc.
  • GE Healthcare
  • KLS Martin Group
  • A&E Medical Corporation
  • Jace Medical, LLC
  • Acute Innovations
  • Abyrx, Inc.
  • Kinamed Incorporated

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Cell Culture Market is Growing at Significant Rate, 2028: Grand View Research Inc.

 3D Cell Culture Market Growth & Trends

The global 3D cell culture market size is expected to reach USD 3.48 billion by 2028 registering a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The development of 3D optimized assays, kits, and protocols coupled with the evolution of assay techniques is anticipated to drive the three-dimensional cell culture market.

As 3-dimensional cultures have the capacity to closely mimic a typical morphology and microarchitecture of organs, these are continuously developed for the studies that require in vivo model systems to analyze the effect of a foreign drug over body tissues and organs. This, coupled with the availability of various choices in terms of material and structure of the scaffold for different in vitro applications, is anticipated to support revenue generation for scaffolds.

Recent researches have explored the use of a diverse range of scaffolds including graphene scaffolds, nanofibers, freeze-casting, natural marine collagen, and others. In addition, the application of lab-on-a-chip techniques in several assay types-proliferation, viability, stimulation, transport, patch clamping, high content screening, and metabolic activity-leads to a rise in demand for projects with advanced and efficient solutions.

Request a free sample copy or view report summary: 3D Cell Culture Market Report

3D Cell Culture Market Report Highlights

  • The scaffold-based technology segment is anticipated to register a lucrative year-on-year growth owing to rising demand for 3D model-based research coupled with an increased incidence of chronic diseases
  • Moreover, the introduction of novel tools and techniques is anticipated to boost revenue generation in the scaffold-based technology segment
  • Furthermore, companies, such as Tecan and Sigma-Aldrich, offer scaffold-based 3D solutions; which are readily adopted by the end users
  • Cancer was the largest application segment of the market in 2020. This is because 3D cultures efficiently replicate the associated influences and complexity of in vivo tumor microenvironment including the impact of extracellular matrix and cell-to-cell contact
  • Cells in 3-dimensional cultures help in the analysis of behavior and properties of the tumor, protein distribution, gene expression, and monitor response to anticancer therapies
  • Potential scientific and clinical impacts of the 3D-cultivation approach for embryonic, adult, and cancer stem cells are estimated to boost the growth of the stem cell research segment
  • Biotechnology and pharmaceutical organizations accounted for the largest share in 2020 owing to a rise in the adoption of 3D cell culture techniques in tissue engineering and drug discovery
  • Combination of 3D cell culture techniques with Human-induced Pluripotent Stem Cells (HiPSCs) has been successfully used for the development and discovery of drugs for liver diseases
  • North America led the market in 2020 owing to extensive usage of 3D cell culture models for medical research purposes
  • In April 2020, a team of researchers from the University of Pittsburgh used Multicellular Tumor Spheroids (MCTSs) to assess drug responses in drug screening studies for oncology
  • Asia Pacific is expected to register the fastest CAGR from 2021 to 2028 due to rising investments by North American and European companies in APAC regional market
  • The key market players focus on geographical expansions, partnerships, collaborations, acquisitions, and novel product launches to reinforce their market presence
  • For instance, in December 2020, Curiteva, Inc. acquired FossiLabs, LLC. The latter has developed a process to fabricate scaffolding structures that promote osseointegration

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-cell-culture-market

3D Cell Culture Market Segmentation

Grand View Research has segmented the global 3D cell culture market on the basis of technology, application, end use, and region:

3D Cell Culture Technology Outlook (Revenue, USD Million, 2016 - 2028)

  • Scaffold-based
    • Hydrogels
    • Polymeric Scaffolds
    • Micro-patterned Surface Microplates
    • Nanofiber-based Scaffolds
  • Scaffold-free
    • Hanging Drop Microplates
    • Microfluidic 3D Cell Culture
    • Spheroid Microplates with ULA coating
    • Magnetic Levitation & 3D Bioprinting
  • Bioreactors

3D Cell Culture Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Cancer
  • Tissue Engineering & Immunohistochemistry
  • Drug Development
  • Stem Cell Research
  • Others

3D Cell Culture End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Biotechnology and Pharmaceutical Industries
  • Research Laboratories and Institutes
  • Hospitals and Diagnostic Centers
  • Others

3D Cell Culture Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

List of Key Players of 3D Cell Culture Market

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • PromoCell GmbH
  • Greiner Bio One International GmbH
  • Corning, Inc.
  • 3D Biomatrix
  • Lonza
  • Avantor Performance Materials, LLC
  • Tecan Trading AG
  • 3D Biotek LLC
  • Global Cell Solutions, Inc.
  • InSphero

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Bioprinting Market Will See Strong Expansion Through 2028: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

  • The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
  • The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
  • North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

  • Inkjet-based
  • Magnetic Levitation
  • Syringe-based
  • Laser-based
  • Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Medical
    • Tissue and organ generation
    • Medical pills
    • Prosthetics and implants
  • Dental
  • Biosensors
  • Consumer/Personal Product Testing
  • Bioinks
  • Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Columbia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of 3D Bioprinting Market

  • Envisiontec, Inc.
  • Organovo Holdings, Inc.
  • Inventia Life Science PTY LTD
  • Poietis
  • Vivax Bio, LLC
  • Allevi
  • Cyfuse Biomedical K.K.
  • 3D Bioprinting Solutions
  • Cellink Global
  • Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Vitro Diagnostics Market Trends, Growth Prospects To 2027: Grand View Research Inc.

 In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

Request a free sample copy or view report summary: In Vitro Diagnostics Market Report

In Vitro Diagnostics Market Report Highlights

  • Molecular diagnostics is expected to witness the fastest growth over the forecast period
  • High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests
  • Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa
  • The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments
  • Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-market

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in-vitro diagnostics market based on the product, technology, application, end-use, and region:

In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Instruments
  • Reagents
  • Services

In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2016 - 2027)

  • Immunoassay
    • Instruments
    • Reagents
    • Services
  • Hematology
    • Instruments
    • Reagents
    • Services
  • Clinical Chemistry
    • Instruments
    • Reagents
    • Services
  • Molecular Diagnostics
    • Instruments
    • Reagents
    • Services
  • Coagulation
    • Instruments
    • Reagents
    • Services
  • Microbiology
    • Instruments
    • Reagents
    • Services
  • Others
    • Instruments
    • Reagents
    • Services

In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Disease
  • Drug testing
  • Others

In Vitro Diagnostics End-use Outlook (Revenue, USD Million, 2016 - 2027)

  • Hospitals
  • Laboratories
  • Home Care
  • Others

In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Singapore
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

List of Key Players of In Vitro Diagnostics Market

  • Abbott
  • Danaher
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Siemens Healthineers AG
  • QIAGEN
  • Quidel Corporation
  • Hoffmann-La Roche AG
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • Quest Diagnostics
  • Agilent Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology Market is Projected To Grow Moderately at 15.83% CAGR from 2021 to 2028: Grand View Research Inc.

 

Biotechnology Market Growth & Trends

The global biotechnology market size is expected to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.

Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

The bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Request a free sample copy or view report summary: Biotechnology Market Report

Biotechnology Market Report Highlights

  • The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
  • The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
  • North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
  • For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
  • Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biotechnology-market

Biotechnology Market Segmentation

Grand View Research has segmented the global biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Billion, 2017 - 2028)

  • Nanobiotechnology
  • Tissue Engineering And Regeneration
  • DNA Sequencing
  • Cell-based Assays
  • Fermentation
  • PCR Technology
  • Chromatography
  • Others

Biotechnology Application Outlook (Revenue, USD Billion, 2017 - 2028)

  • Health
  • Food & Agriculture
  • Natural Resources & Environment
  • Industrial Processing
  • Bioinformatics
  • Others

Biotechnology Regional Outlook (Revenue, USD Billion, 2017 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • Spain
    • France
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

List of Key Players of Biotechnology Market

  • AstraZeneca
  • Gilead Sciences, Inc.  
  • CELGENE CORPORATION
  • Biogen
  • Abbott
  • Amgen Inc.
  • Novo Nordisk A/S
  • Merck & Co.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Sanofi
  • Hoffmann-La Roche Ltd.
  • Pfizer, Inc.
  • Lonza

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Smart Display Market Latest Trends, Industry Growth And Forecast To 2028: Grand View Research Inc.

 Automotive Smart Display Market Growth & Trends

The global automotive smart display market size is expected to reach USD 16.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2021 to 2028. The growing demand for advanced safety features, automotive and cockpit electronics, and semi-autonomous and autonomous vehicles is expected to drive the market. The increasing demand for improved in-vehicle experience and the changing consumer buying behavior, along with the growth of luxury, premium, and high-end cars worldwide, are also expected to fuel the market demand over the forecast period.

The surge in demand for vehicle navigation and connectivity system in the automotive sector led to a growth in the usage of automotive visualization technology. The visualization technology has played a significant role in the advancement of the cockpit technology, which has led to the incorporation of interactive and smart displays in several vehicles launched by prominent automakers, such as Jaguar Land Rover, Mercedes-Benz, Volkswagen, Audi, and BMW. Moreover, the technology is gaining prominence among automotive display suppliers with an uptick in demand for automotive in-vehicle infotainment solutions as well as display solutions. An increase in the sales of passenger vehicles equipped with smart displays and in-vehicle infotainment systems, coupled with features such as navigation, driver assistance, and real-time traffic monitoring, is expected to bolster the market growth over the forecast period.

Asia Pacific held the largest share in 2020 owing to the presence of several key players, such as Panasonic Corporation (Japan), Yazaki (Japan), and Nippon Seiki (Japan) in the region. The region is characterized by the presence of developed nations such as Japan and South Korea, along with emerging economies such as China and India. In recent years, the region has emerged as a hub for automobile production.

Request a free sample copy or view report summary: Automotive Smart Display Market Report

Automotive Smart Display Market Report Highlights

  • In terms of display size, the greater than 10" size segment is expected to register the highest CAGR of 9.2% from 2021 to 2028 owing to the increase in the number of semi-autonomous, autonomous, and electric cars
  • Based on display technology, the TFT-LCD segment dominated the market in 2020 and is anticipated to maintain its lead the forecast period
  • By application, the center stack segment accounted for the largest revenue share of over 40.0% in 2020. Technological developments in self-driving and connected cars are expected to propel the demand for center stack displays in vehicles
  • Asia Pacific accounted for the largest revenue share in 2020. This is attributed to increased production and sales of passenger vehicles in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-smart-display-market

Automotive Smart Display Market Segmentation

Grand View Research has segmented the global automotive smart display market on the basis of display size, display technology, application, and region:

Automotive Smart Display Size Outlook (Revenue, USD Billion, 2016 - 2028)

  • Less than 5''
  • 5''- 10''
  • Greater than 10''

Automotive Smart Display Technology Outlook (Revenue, USD Billion, 2016 - 2028)

  • LCD
  • TFT-LCD
  • OLED
  • Others

Automotive Smart Display Application Outlook (Revenue, USD Billion, 2016 - 2028)

  • Digital Instrument Cluster
  • Center Stack
  • Head-up Display (HUD)
  • Rear Seat Entertainment

Automotive Smart Display Regional Outlook (Revenue, USD Billion, 2016 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

List of Key Players of Automotive Smart Display Market

  • Alps Alpine Co., Ltd.
  • Continental AG
  • Denso Corporation
  • Hyundai Mobis
  • Nippon Seiki Co., Ltd.
  • Panasonic Corporation
  • Pioneer Corporation
  • Robert Bosch GmbH
  • SAMSUNG (HARMAN International)
  • Visteon Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Cell Therapy Raw Materials Market Is Projected To Reach Approximately $9.37 Billion By 2033: Grand View Research Inc.

  U.S. Cell Therapy Raw Materials Market Growth & Trends The  U.S. cell therapy raw materials market  size is anticipated to reach USD 9...